CUTIA-B News

CUTIA-B: Next Day Disclosure Return

Oct 17 18:06 ET

CUTIA-B: VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY THE CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR

Oct 16 18:06 ET

CUTIA-B: Next Day Disclosure Return

Oct 16 18:02 ET

科笛-B：翌日披露報表

Oct 14 18:02 ET

CUTIA-B: VOLUNTARY ANNOUNCEMENT -INCREASE IN SHAREHOLDING BY THE CHIEF EXECUTIVE OFFICERAND EXECUTIVE DIRECTOR

Oct 13 20:15 ET

CUTIA-B: Next Day Disclosure Return

Oct 9 18:05 ET

CUTIA-B: VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY THE CHIEF FINANCIAL OFFICER AND EXECUTIVE DIRECTOR

Oct 8 18:04 ET

CUTIA-B: Next Day Disclosure Return

Oct 8 18:02 ET

CUTIA-B: VOLUNTARY ANNOUNCEMENT -INCREASE IN SHAREHOLDING BY THE CHIEF FINANCIAL OFFICERAND EXECUTIVE DIRECTOR

Oct 8 00:00 ET

CUTIA-B: Next Day Disclosure Return

Oct 7 18:05 ET

CUTIA-B: Next Day Disclosure Return

Oct 6 20:07 ET

CUTIA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024

Oct 4 09:00 ET

CUTIA-B: Next Day Disclosure Return

Oct 3 18:06 ET

CUTIA-B: Next Day Disclosure Return

Oct 2 18:04 ET

CUTIA-B: VOLUNTARY ANNOUNCEMENT -ALL ENROLLED PATIENTS COMPLETEDPHASE II CLINICAL TRIAL OF CU-20401(RECOMBINANT MUTANT COLLAGENASE) FORSUBMENTAL ADIPOSE ACCUMULATION

Sep 29 20:01 ET

CUTIA-B: VOLUNTARY ANNOUNCEMENT - FIRST PATIENT ENROLLED IN THE PHASE I CLINICAL TRIAL OFCU-10101 (TOPICAL NOVEL SMALL MOLECULE AGENT)FOR ATOPIC DERMATITIS

Sep 27 00:01 ET

CUTIA-B: Next Day Disclosure Return

Sep 26 18:19 ET

CUTIA-B: Next Day Disclosure Return

Sep 25 18:01 ET

CUTIA-B: Next Day Disclosure Return

Sep 24 18:02 ET

CUTIA-B: Next Day Disclosure Return

Sep 23 07:40 ET